The Hyderabad based pharma company, Bharat Biotech International Private limited agreed to pay compensation if shows adverse side effects on people. Vaccine recipients receiving Bharat Biotech manufactured COVAXIN, would have…
Balram Bhargava, the Chief of the Indian Council of Medical Research (ICMR) asked the Bharat Biotech International Private Limited to take consent from volunteers. On the 5th of January, the…
On the 12th of September, Hyderabad based Bharat Biotech’s Novel Coronavirus or COVID-19 vaccine candidate COVAXIN, showed successful results on animals. According to the sources, the potential vaccine showed efficacy…
Human trials of India’s first potential vaccine for the Novel Coronavirus or COVID-19 began in Uttar Pradesh on the 31st of July. After Telangana’s Nizam’s Institute of Medical Science and…
The Nizam’s Institute of Medical Sciences (NIMS) recently began the clinical trials of COVAXIN, a potential vaccine for the Novel Coronavirus or COVID-19. On the 22nd of July, the NIMS…
